Mohamed Fareh
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
CRISPR in clinical oncology: translational advances from molecular diagnostics to therapeutics.
Journal: Nature reviews. Clinical oncology
Published: June 10, 2026
Systematic evaluation of CrRNA design parameters for optimized Cas13d-mediated RNA targeting in chicken cells.
Journal: Functional & integrative genomics
Published: September 02, 2025
De novo design of potent CRISPR-Cas13 inhibitors.
Journal: Nature chemical biology
Published: January 19, 2025
Efficient mRNA delivery to resting T cells to reverse HIV latency.
Journal: Nature communications
Published: January 11, 2025
Principles of CRISPR-Cas13 mismatch intolerance enable selective silencing of point-mutated oncogenic RNA with single-base precision.
Journal: Science advances
Published: December 18, 2024
CRISPR-Cas13b-mediated suppression of HBV replication and protein expression.
Journal: Journal of hepatology
Published: September 26, 2023
Single-base tiled screen unveils design principles of PspCas13b for potent and off-target-free RNA silencing.
Journal: Nature structural & molecular biology
Published: April 17, 2023
Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.
Journal: Nature communications
Published: November 23, 2020
Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition.
Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition.
Journal: Molecular cell
Published: January 28, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026